Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 16 of 16 entries
View as:

Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06147492 Org: User:
Start: 01/30/16 End: 10/30/23 Due: 10/30/24

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06143605 Org: User:
Start: 01/30/13 End: 09/30/23 Due: 09/30/24

Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06879197 Org: User:
Start: 04/30/16 End: 03/30/23 Due: 03/30/24

Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05360277 Org: User:
Start: 08/22/23 End: 11/30/27 Due: 11/30/28

Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06898359 Org: User:
Start: 05/20/22 End: 08/28/23 Due: 08/28/24

PRP Prevents Recurrence of Intrauterine Adhesions

Phase: N/A Priority: Normal
NCT ID: NCT03629132 Org: User:
Start: 08/15/18 End: 12/30/19 Due: 12/30/20

Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03548844 Org: User:
Start: 05/24/18 End: 05/31/23 Due: 05/31/24

Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)

Phase: N/A Priority: Normal
NCT ID: NCT05427669 Org: User:
Start: 10/09/22 End: 07/01/27 Due: 07/01/28

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Phase: N/A Priority: Normal
NCT ID: NCT06900686 Org: User:
Start: 03/20/13 End: 03/23/25 Due: 03/23/26

Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04215731 Org: User:
Start: 03/27/20 End: 02/01/26 Due: 02/01/27

Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05450029 Org: User:
Start: 01/01/22 End: 01/01/27 Due: 01/01/28

Laparoscopic Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) for Colorectal Liver Metastases (CRLM)

Phase: N/A Priority: Normal
NCT ID: NCT06779474 Org: User:
Start: 05/01/25 End: 05/01/30 Due: 05/01/31

Oncological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05201885 Org: User:
Start: 01/15/22 End: 02/28/26 Due: 02/28/27

Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06883084 Org: User:
Start: 01/30/14 End: 02/25/26 Due: 02/25/27

Bacteriological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05201872 Org: User:
Start: 01/15/22 End: 04/30/23 Due: 04/30/24

Bevacizumab Plus MFOLFOXIRI As First-line Treatment for Patients with Unresectable Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04230187 Org: User:
Start: 06/01/20 End: 06/01/26 Due: 06/01/27